Lysosome blockade induces divergent metabolic programs in macrophages and tumours for cancer immunotherapy
Abstract Background Platinum-drugs based chemotherapy in clinic increases the potency of tumor cells to produce M2 macrophages, thus leading to poor anti-metastatic activity and immunosuppression. Lysosome metabolism is critical for cancer cell migration and invasion, but how it promotes antitumor i...
Main Authors: | Jing Ma, Ruijuan Ma, Xueke Zeng, Liming Zhang, Jianing Liu, Wei Zhang, Tao Li, Hanjing Niu, Guochen Bao, Chaojie Wang, Peng George Wang, Jiajia Wang, Xia Li, Taotao Zou, Songqiang Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Online Access: | https://doi.org/10.1186/s13046-023-02768-0 |
Similar Items
-
pH-gated nanoparticles selectively regulate lysosomal function of tumour-associated macrophages for cancer immunotherapy
by: Mingmei Tang, et al.
Published: (2023-09-01) -
The significance of targeting lysosomes in cancer immunotherapy
by: Yanxin Xu, et al.
Published: (2024-02-01) -
Older but Stronger: Development of Platinum-Based Antitumor Agents and Research Advances in Tumor Immunity
by: Jianing Liu, et al.
Published: (2023-03-01) -
Immunotherapies: The Blockade of Inhibitory Signals
by: Yan-Ling Wu, Jing Liang, Wen Zhang, Yoshimasa Tanaka, Hiroshi Sugiyama
Published: (2012-01-01) -
Epigenetic checkpoint blockade: new booster for immunotherapy
by: Ziqiao Wang, et al.
Published: (2021-07-01)